Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
CMS confirmed in April 2026 that the participation threshold for BALANCE in Medicare Part D was not met for 2027
Stock room materials are supplied as lyophilized freeze-dried powder in 3mL sealed research vials
Don't rely on memory
Coming off GLP-1 medication is a decision for you and your prescribing clinician
In the U.S., private insurers and employers are figuring out whether and how to cover these weight-loss drugscoverage and cost-sharing will likely vary by health plan
Research in people using GLP-1s for obesity shows: Nausea, vomiting, diarrhea and constipation are the leading side effects.Nature+1 The risk of these symptoms typically increases with dose, especially during dose escalation.Nature+1 Constipation in particular is reported more often in obesity trials than in diabetes trials.Taylor & Francis Online+1 In everyday language: your digestive system is being asked to slow down and adjust, while your eating patterns and appetite are changingsometimes dramatically and quickly
US$ 25.26
US$ 28.69
US$ 26.67
